C4 Therapeutics, Inc.
Ticker: 1662579
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.15-45.2% | 11.23+73.8% | 6.46-10.8% | 7.24-52.9% | 15.36+27.9% | 12.01+295.1% | 3.04-72.5% | 11.07 |
| Total Income | 6.15-45.2% | 11.23+73.8% | 6.46-10.8% | 7.24-52.9% | 15.36+27.9% | 12.01+295.1% | 3.04-72.5% | 11.07 |
| EXPENSES | ||||||||
| Expenditure | 33.94-25.6% | 45.64+30.5% | 34.96-4.0% | 36.40-16.5% | 43.61+30.4% | 33.45-5.1% | 35.26-9.3% | 38.88 |
| Tax | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.00 |
| PROFIT | ||||||||
| PBT | — | -32.17-23.6% | -26.02+1.1% | -26.32-6.7% | -24.67-39.2% | -17.72+37.5% | -28.36-9.0% | -26.03 |
| Net Profit | -25.13+21.9% | -32.17-23.6% | -26.02+1.1% | -26.32-6.7% | -24.67-39.2% | -17.72+37.5% | -28.36-4.9% | -27.04 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.20+54.5% | -0.44-18.9% | -0.37+0.0% | -0.37-5.7% | -0.35-34.6% | -0.26+36.6% | -0.41+25.5% | -0.55 |
Corporate Events
Board MeetingCCCC
202624Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of Cl…
SEC Filing ↗ Board MeetingCCCC
202615May
Board Meeting
Chief Accounting Officer Transition — Mark Mossler departs, …
SEC Filing ↗